Neubase Therapeutics Inc. (NBSE)

Market is closed

Insider Trading: Purchases

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Hirschman Director	$0.70	171,429	$120,000.30	1,678,177	2017-04-10	Filing
Slakter Officer, Director	$0.70	142,858	$100,000.60	1,067,898	2017-04-10	Filing
Backenroth Officer	$0.70	71,429	$50,000.30	212,596	2017-04-10	Filing
Hirschman Director	$0.70	142,858	$100,000.60	1,649,605	2017-04-10	Filing
Slakter Officer, Director	$2.71	550	$1,490.50	925,040	2016-06-20	Filing
Slakter Officer, Director	$2.83	1	$2.83	924,490	2016-06-20	Filing
Slakter Officer, Director	$2.84	5,431	$15,424.04	924,489	2016-06-20	Filing
Slakter Officer, Director	$2.87	1,019	$2,924.53	919,058	2016-06-20	Filing
Slakter Officer, Director	$2.88	85	$244.80	918,039	2016-06-20	Filing
Slakter Officer, Director	$2.89	1,700	$4,913.00	917,954	2016-06-20	Filing
Backenroth Officer	$2.71	200	$542.00	141,167	2016-06-20	Filing
Backenroth Officer	$2.84	1,800	$5,112.00	140,967	2016-06-20	Filing
Backenroth Officer	$2.87	450	$1,291.50	139,167	2016-06-20	Filing
Backenroth Officer	$2.88	8	$23.04	138,717	2016-06-20	Filing
Backenroth Officer	$2.89	10	$28.90	138,709	2016-06-20	Filing
Slakter Officer, Director	$3.10	2,000	$6,200.00	916,254	2016-05-25	Filing
Slakter Officer, Director	$3.13	682	$2,134.66	914,254	2016-05-25	Filing
Slakter Officer, Director	$3.14	100	$313.99	913,572	2016-05-25	Filing
Slakter Officer, Director	$3.14	300	$942.00	913,472	2016-05-25	Filing
Slakter Officer, Director	$3.11	100	$311.00	913,172	2016-05-25	Filing